Last reviewed · How we verify
Tiragolumab and Atezolizumab IV FDC
Tiragolumab and Atezolizumab IV FDC is a Small molecule drug developed by Hoffmann-La Roche. It is currently in Phase 2 development.
At a glance
| Generic name | Tiragolumab and Atezolizumab IV FDC |
|---|---|
| Sponsor | Hoffmann-La Roche |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors (PHASE2)
- A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer (PHASE2)
- A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tiragolumab and Atezolizumab IV FDC CI brief — competitive landscape report
- Tiragolumab and Atezolizumab IV FDC updates RSS · CI watch RSS
- Hoffmann-La Roche portfolio CI
Frequently asked questions about Tiragolumab and Atezolizumab IV FDC
What is Tiragolumab and Atezolizumab IV FDC?
Tiragolumab and Atezolizumab IV FDC is a Small molecule drug developed by Hoffmann-La Roche.
Who makes Tiragolumab and Atezolizumab IV FDC?
Tiragolumab and Atezolizumab IV FDC is developed by Hoffmann-La Roche (see full Hoffmann-La Roche pipeline at /company/roche).
What development phase is Tiragolumab and Atezolizumab IV FDC in?
Tiragolumab and Atezolizumab IV FDC is in Phase 2.